Navigation Links
PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
Date:12/21/2011

BOSTON, Dec. 21, 2011 /PRNewswire/ -- To help emerging and mid-size biopharmaceutical companies address an increasingly challenging regulatory and commercial environment, PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it is introducing a series of executive briefings with clinical operations and outsourcing leaders worldwide.  During these forums, PAREXEL will discuss how a spectrum of proven operating practices and relationship models can significantly reduce timelines and costs and streamline protocols and programs.

Through these educational briefings, designed for emerging and mid-size biopharmaceutical companies, PAREXEL senior project leaders and teams will discuss customized solutions that can assist companies in achieving their short- and long-term development and commercialization milestones. The teams will address key issues that may impact critical areas for emerging and mid-sized biopharmaceutical companies, including:

  • Optimizing patient recruitment strategy
  • Meeting "first patient in" timelines
  • Accessing real-time data
  • Achieving database lock timelines
  • Accelerating the speed of site recruitment
  • Implementing risk management and contingency planning approaches
  • "Deep collaboration with emerging and mid-size biopharmaceutical companies has been part of our DNA for nearly 30 years. We are committed to continuing to work with these clients to help them navigate the next stages of their businesses in the 'niche-buster' era, and in a challenging regulatory and commercial environment," said Mark A. Goldberg, M.D., Chief Operating Officer, PAREXEL. "Through a flexible and innovative approach, we create solutions that are the 'right fit' for every client. We're looking forward to bringing th
    '/>"/>

    SOURCE PAREXEL International Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. PAREXEL Closes the Acquisition of ClinPhone
    2. PAREXEL Data Indicate U.S. Marketing Applications for New Molecular Entities Bounce Back
    3. PAREXEL International To Present at Thomas Weisel Partners Healthcare Conference
    4. PAREXEL International Updates Financial Guidance in Conjunction With the Acquisition of ClinPhone Plc and Other Factors
    5. PAREXEL International to Present at William Blair Small-Cap Growth Stock Conference
    6. PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average
    7. PAREXEL Corporate Vice President Dr. Alberto Grignolo Receives Lifetime Achievement Award From Good Clinical Practice Journal
    8. PAREXEL Partners with Glenmark to Win the Good Clinical Practice Journal Award for Most Innovative Patient Recruitment Strategy
    9. PAREXEL International to Present at Oppenheimer 19th Annual Healthcare Conference
    10. PAREXEL Expert to Address Key Aspects of Conducting Clinical Trials in China at 7th Annual Partnerships in Clinical Trials Congress
    11. PAREXEL Expands Pioneering Asian Ethnobridging Expertise
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/2/2015)... , July 2, 2015  Spherix Incorporated (Nasdaq: ... the fostering and monetization of intellectual property, today announced ... Spherix Incorporated v. Verizon Services Corp. et al. ... Court for the Eastern District of Virginia ... July 1, 2015 interpreting certain key claims in favor ...
    (Date:7/1/2015)... ... 01, 2015 , ... It is now possible to separate two common disorders: ... computed tomography (SPECT) according to researchers from Amen Clinics, UCLA, Thomas Jefferson University, ... and is believed to be the largest brain imaging study ever, will be published ...
    (Date:7/1/2015)... and BANGALORE, India , July 1, ... company that uses next generation sequencing technology to empower ... A. Storrer as chief executive officer. In his ... be responsible for all strategy, business expansion and worldwide ... has served as Strand,s chairman and CEO since its ...
    (Date:7/1/2015)... ... ... A newly launched business plan contest will ask startup companies from around the ... R&D. The Pistoia Alliance President’s Startup Challenge 2015 will see small and medium enterprises ... mentorship from a senior industry figure drawn from the Pistoia Alliance membership. , The ...
    Breaking Biology Technology:Spherix Issues A Litigation Update 2Spherix Issues A Litigation Update 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3
    ... Insmed Inc.,(Nasdaq: INSM ), a developer ... unmet medical needs, announced today that it has,entered into ... Merck,through an affiliate, will purchase all assets related to ... agreement, Insmed will receive a,total of $130 million for ...
    ... Realty Trust, Inc. (NYSE: BMR ) announced ... acquisition and interim loan facility originally entered into in ... managed by Prudential Real Estate Investors to acquire, among ... space in Cambridge, Massachusetts.Proceeds from the refinancing were approximately ...
    ... Technologies, Inc. ("OriGene") today announced it has raised ... financing. With this financing, OriGene completed the acquisition ... Biotech, a manufacturer and provider of monoclonal antibodies ... OriGene completes the establishment of its technology center ...
    Cached Biology Technology:Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million 2Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million 3Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million 4BioMed Realty Trust Announces New Financing for Joint Venture With Prudential Real Estate Investors 2BioMed Realty Trust Announces New Financing for Joint Venture With Prudential Real Estate Investors 3BioMed Realty Trust Announces New Financing for Joint Venture With Prudential Real Estate Investors 4OriGene Technologies, Inc. Establishes High Throughput Monoclonal Antibody Production Outsourcing Center in China 2
    (Date:6/30/2015)... -- Genisphere announced Tom Bliss ... develop Genisphere,s therapeutics capabilities and portfolio. Mr. Bliss comes ... of the last 25 years in leadership positions at ... & Johnson. Tom started his career in Investment Banking, ... He graduated from Dartmouth College with a BA in ...
    (Date:6/25/2015)... June 25, 2015 According ... Type (Swipe & Area), Technology, Material (Optical Prism, ... Commercial Security & Others) & Geography - Global ... the said market is expected to reach $14,500.07 ... Browse 76 market Tables and ...
    (Date:6/24/2015)... , June 24, 2015 The biologics safety ... major drivers for the market include growth of the ... new drug launches. Over the years, the number of ... 2001 and 2010, the FDA approved 225 drug applications ... WIPO, Europe accounted for 3,822 ...
    Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4
    ... animals in Earth,s history, are still mightily puzzling the scientists. ... could reach a height of 10 meters or more and ... could weigh up to 80 tons, more than any other ... is how these giants of the animal kingdom regulated their ...
    ... make calculated decisions that allow them to obtain the most ... hypothesis called economic man for short often has been ... information to make the best decision, and they sometimes act ... critiques is as radical as the one advanced in the ...
    ... 2014 Research ... addition of the  "Global Bioinformatics Market 2013 ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... the various sectors covered in this report ...
    Cached Biology News:New research on sauropod gigantism summarized in publicly available collection 2New research on sauropod gigantism summarized in publicly available collection 3Microbes buy low and sell high 2Microbes buy low and sell high 3Global Bioinformatics Market 2013 - 2017 2Global Bioinformatics Market 2013 - 2017 3